Skip to main content
. 2022 Feb 23;29(1):53–61. doi: 10.5603/CJ.a2020.0039

Figure 3.

Figure 3

Influence of systemic antithrombotic prophylaxis on continuous renal replacement therapy (CRRT) circuit lifespan. (Group A: No antithrombotic prophylaxis or acetylsalicylic acid [ASA] only, Group B: prophylactic dose low molecular weight heparin [LMWH] or fondaparinux with or without ASA, Group C: more than prophylactic dose LMWH or fondaparinux with or without ASA).